IGO
IGO remains under watch as we wait for the buying momentum to pick up.
IGO remains under watch as we wait for the buying momentum to pick up.
Boss Energy is producing uranium, and therefore can take advantage of the current high price. Uranium prices have doubled in 2023 and are now trading at 15-year highs of US$87/lb.
12/1 Earlier this week, the price hit a 16-year high above $US93 per pound, after the US Department of Energy ramped up its $US500 million ($747.5 million) plan to secure a domestic supply of enriched uranium, which it currently sources from Russia.
11/1 update:
8/1 update
At the start of 2023, we added 5 ETFs to the Investor Signals Global Growth portfolio. For the 12 months, the portfolio returned 80% with the bulk of the gains attributed to Cyber Security, Cloud Computing, and Fang.
We will be building the tracking portfolio of our favored funds for 2024 and covering these in our next public webinar.
STO shares remain heavily discounted, given superior free cash flow. Barossa project progression, completion of PNG selldown, and the potential merger proposal from WDS are all positive catalysts.
We expect STO to report a solid 4Q on 25th January and we look to buy STO on the current dip in price.
NAS: MDB is a buy with a suggested stop loss below $360.
Third Quarter Fiscal 2024 Financial Highlights
These are the ASX 100 group of stocks that are under algo engine buy conditions and have a green pivot point arrow. ILU, SOL, TNA, QBE, AGL & IGO.
ILU, SOL, TNE & QBE are trading above the 10-day average. The only trade we’ve set is long ILU with a stop loss at $6.39
Bellevue Gold shifts to an “accumulate” rating within the $1.30 – $1.50 price range.
Gold Road Resources offers an opportunity for investors looking for gold exposure.
Boss Energy is producing uranium, and therefore can take advantage of the current high price. Uranium prices have doubled in 2023 and are now trading at 15-year highs of US$87/lb.
11/1 update:
8/1 update
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Or start a free thirty day trial for our full service, which includes our ASX Research.